4 results for “Anticoagulation”

Set a search alert

Research ArticleOpen accessIn the keywordsStroke Prevention in Atrial Fibrillation: Pharmacologic UpdateWajeeha Saeed, J. W. Kusick, M. R. Sardar et al.For nearly half a century, the therapeutic options for the risk reduction of stroke in atrial fibrillation have been stagnant with vitamin K antagonists, such as warfarin, being the primary therapy. Although antiplatelet agents have been investigated over this time, they were never shown to reduce the risk of stroke at the level warfarin has. Considering the limited therapeutic options, … …Current Research in Medicine, Vol. 4, Issue 2 · 24 Jun 2013 · 6,762 accessesView PDF Cite

Research ArticleOpen accessIn the keywordsRivaroxaban and its Effect on International Normalised Ratio-A Prospective Study of 28 Hip and Knee Arthroplasty PatientsV. Eranki, A. Pillai, G. Morrison, Cheng Hong YeoProblem statement: Rivaroxaban is an orally active, competitively reversible antagonist of activated factor Xa. The purpose of this study is to comment on Riveroxaban’s effect on INR. Approach: At the Queen Elizabeth Hospital, all patients undergoing elective anthroplasty were anticoagulated with 10mg of Rivaroxaban. All patients had INR measurements for 3 days post operatively. Further 16 patients had weekly INR … …Current Research in Medicine, Vol. 3, Issue 2 · 12 Jul 2012 · 21,044 accessesView PDF Cite

Case ReportOpen accessIn the abstractIdentification and Management Implications of Fusobacterium Nucleatum PylephlebitisShoja Rahimian, Maria Labra, Ian Garrahy et al.Suppurativethrombophlebitis of the portal vein, or pylephlebitis, is a rare infectious manifestation. Only few casesresulting from Fusobacterium species have been reported, demonstratingthe disease that is in some ways analogous to Lemierre’s syndrome, orsuppurative thrombophlebitis of the internal jugular vein. Of these, Fusobacteriumnucleatum represents an important subtype with unique colon cancer risk.With high mortality rates up to 32% being described in … …American Journal of Infectious Diseases, Vol. 18, Issue 3 · 26 Sep 2022 · 5,689 accessesView PDF Cite

Research ArticleOpen accessIn the abstractIn-Depth Review of Stroke Prevention in Patients with Non-Valvular Atrial FibrillationDaych Chongnarungsin, Supawat Ratanapo, Narat Srivali et al.Stroke is a common complication of atrial fibrillation that leads to high morbidity. Anticoagulation therapy significantly reduces the risk of stroke in a selected group of patients. The decision to start anticoagulation needs to be balanced with bleeding risk. During the past years, multiple oral anticoagulation agents were proven to be as effective as warfarin in multiple randomized clinical trials. … …Current Research in Medicine, Vol. 3, Issue 2 · 22 May 2012 · 12,564 accessesView PDF Cite